<p>在过去三个月中，5 位分析师对 Chemours（纽约证券交易所代码：CC）的评级展示了看涨和看跌的混合观点。</p>
<p>下表提供了分析师最近评级的简明概述，展示了过去 30 天情绪的变化，并与前几个月进行比较，以提供全面的视角。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看涨</strong></th>
<th align="right"><strong>稍微看涨</strong></th>
<th align="right"><strong>无所谓</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>总评级</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>过去 30 天</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 个月前</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>分析师通过对 12 个月价格目标的评估提供了更深入的见解，显示出平均目标为 17.4 美元，最高预估为 21.00 美元，最低预估为 13.00 美元。当前平均目标较之前的 18.80 美元下降了 7.45%。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769000466_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="价格目标图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769000466_0.png"/></p>
<h2>分析师评级探讨：深入概述</h2>
<p>对金融专家如何看待 Chemours 的全面审查源于最近的分析师行动。以下是关键分析师的详细总结，包括他们的近期评估以及对评级和价格目标的调整。</p>
<table>
<thead>
<tr>
<th>分析师</th>
<th>分析师公司</th>
<th>采取的行动</th>
<th>评级</th>
<th>当前价格目标</th>
<th>之前价格目标</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>上调</td>
<td>买入</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>下调</td>
<td>中性</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>下调</td>
<td>买入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>下调</td>
<td>买入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>下调</td>
<td>超过大盘</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>关键见解：</h3>
<ul>
<li><strong>采取的行动：</strong> 分析师根据市场条件和公司表现调整他们的建议。无论是 “维持”、“上调” 还是 “下调” 他们的立场，反映了他们对 Chemours 近期发展的反应。这些信息提供了分析师对公司当前状态的快照。</li>
<li><strong>评级：</strong> 分析师揭示了对股票的定性评估，范围从 “超过大盘” 到 “低于大盘”。这些评级提供了 Chemours 相对于更广泛市场的表现预期的见解。</li>
<li><strong>价格目标：</strong> 分析师在价格目标的调整中提供了 Chemours 未来价值的估计。比较当前和之前的目标提供了分析师不断变化的预期的见解。</li>
</ul>
<p>将这些分析师评估与关键财务指标结合起来，可以提供 Chemours 市场地位的全面概述。保持信息灵通，并在我们的评级表的帮助下做出明智的决策。</p>
<p>随时了解 Chemours 的分析师评级。</p>
<h2>深入了解 Chemours 的背景</h2>
<p>Chemours 公司是一家化学品供应商。它为包括涂料、塑料、制冷、空调等在内的多个市场提供广泛的工业和特种化学品产品的定制解决方案。公司的运营部门包括钛技术、热能与特种解决方案以及先进性能材料。它的最大收入来自钛技术部门。钛技术部门是 TiO2 颜料的生产商，这是一种优质白色颜料，用于在各种应用中提供白度、亮度、不透明度、耐用性、效率和保护。从地理上看，公司大部分收入来自北美。</p>
<h3>Chemours：深入财务</h3>
<p><strong>市值：</strong> 超过行业标准，公司市值相对于同行处于行业平均水平之上。这强调了其显著的规模和强大的市场地位。</p>
<p><strong>收入下降：</strong> 在过去 3 个月中，Chemours 面临挑战，导致截至 2025 年 9 月 30 日收入增长约下降 <strong>-0.86%</strong>。这意味着公司的顶线收益减少。与同行相比，收入增长落后于行业同行。公司在材料行业的增长率低于同行的平均水平。</p>
<p><strong>净利润率：</strong> Chemours 的净利润率令人印象深刻，超过行业平均水平。公司净利润率为 <strong>4.01%</strong>，显示出强大的盈利能力和有效的成本管理。</p>
<p><strong>股本回报率（ROE）：</strong> Chemours 的 ROE 表现突出，超过行业平均水平。公司 ROE 为 <strong>22.43%</strong>，显示出有效利用股本和强大的财务表现。</p>
<p><strong>资产回报率（ROA）：</strong> Chemours 的 ROA 超越行业基准，达到 <strong>0.8%</strong>。这表明资产管理高效，财务健康状况良好。</p>
<p><strong>债务管理：</strong> Chemours 的债务与股本比率显著高于行业平均水平，达到 <strong>14.82</strong>。这表明对借款资金的依赖较重，增加了财务杠杆的担忧。</p>
<h2>分析师评级是如何确定的？</h2>
<p>分析师评级作为股票表现的重要指标，由银行和金融系统的专家提供。这些专家认真分析公司的财务报表，参与电话会议，并与内部人士交流，以生成个别股票的季度评级。</p>
<p>一些分析师发布他们对增长预估、收益和收入等指标的预测，以提供额外的指导。在使用分析师评级时，重要的是要记住，股票和行业分析师也是人，他们只是向投资者提供他们的意见。</p>
<p>本文由 Benzinga 的自动内容引擎生成，并经过编辑审核。</p>

<p>Chemours（纽约证券交易所代码：CC）在过去三个月内获得了 5 位分析师的混合评级，12 个月的平均目标价为 17.4 美元，较之前的 18.8 美元有所下降。最近的评估显示出从看涨到看跌的情绪范围。主要分析师包括 Peter Osterland（Truist Securities）将目标价上调至 21.00 美元，而 Jeffrey Zekauskas（JP Morgan）则将其下调至 13.00 美元。Chemours 面临约-0.86% 的收入下降，净利润率为 4.01%，股本回报率（ROE）为 22.43%，但 14.82 的高负债权益比引发了对财务杠杆的担忧</p>

<p>Ratings for Chemours (NYSE: CC) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<div class="lb-trans"><p>在过去三个月中，5 位分析师对 Chemours（纽约证券交易所代码：CC）的评级展示了看涨和看跌的混合观点。</p>
</div><p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<div class="lb-trans"><p>下表提供了分析师最近评级的简明概述，展示了过去 30 天情绪的变化，并与前几个月进行比较，以提供全面的视角。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看涨</strong></th>
<th align="right"><strong>稍微看涨</strong></th>
<th align="right"><strong>无所谓</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>总评级</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>过去 30 天</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 个月前</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.4, a high estimate of $21.00, and a low estimate of $13.00. Experiencing a 7.45% decline, the current average is now lower than the previous average price target of $18.80.</p>
<div class="lb-trans"><p>分析师通过对 12 个月价格目标的评估提供了更深入的见解，显示出平均目标为 17.4 美元，最高预估为 21.00 美元，最低预估为 13.00 美元。当前平均目标较之前的 18.80 美元下降了 7.45%。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769000466_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1769000466_0.png"/></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<div class="lb-trans"><h2>分析师评级探讨：深入概述</h2>
</div><p>A comprehensive examination of how financial experts perceive Chemours is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>对金融专家如何看待 Chemours 的全面审查源于最近的分析师行动。以下是关键分析师的详细总结，包括他们的近期评估以及对评级和价格目标的调整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析师</th>
<th>分析师公司</th>
<th>采取的行动</th>
<th>评级</th>
<th>当前价格目标</th>
<th>之前价格目标</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>上调</td>
<td>买入</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>下调</td>
<td>中性</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>下调</td>
<td>买入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>下调</td>
<td>买入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>下调</td>
<td>超过大盘</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>关键见解：</h3>
</div><ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Chemours. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Chemours compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Chemours's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>采取的行动：</strong> 分析师根据市场条件和公司表现调整他们的建议。无论是 “维持”、“上调” 还是 “下调” 他们的立场，反映了他们对 Chemours 近期发展的反应。这些信息提供了分析师对公司当前状态的快照。</li>
<li><strong>评级：</strong> 分析师揭示了对股票的定性评估，范围从 “超过大盘” 到 “低于大盘”。这些评级提供了 Chemours 相对于更广泛市场的表现预期的见解。</li>
<li><strong>价格目标：</strong> 分析师在价格目标的调整中提供了 Chemours 未来价值的估计。比较当前和之前的目标提供了分析师不断变化的预期的见解。</li>
</ul>
</div><p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Chemours's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<div class="lb-trans"><p>将这些分析师评估与关键财务指标结合起来，可以提供 Chemours 市场地位的全面概述。保持信息灵通，并在我们的评级表的帮助下做出明智的决策。</p>
</div><p>Stay up to date on Chemours analyst ratings.</p>
<div class="lb-trans"><p>随时了解 Chemours 的分析师评级。</p>
</div><h2>Delving into Chemours's Background</h2>
<div class="lb-trans"><h2>深入了解 Chemours 的背景</h2>
</div><p>The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal &amp; Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.</p>
<div class="lb-trans"><p>Chemours 公司是一家化学品供应商。它为包括涂料、塑料、制冷、空调等在内的多个市场提供广泛的工业和特种化学品产品的定制解决方案。公司的运营部门包括钛技术、热能与特种解决方案以及先进性能材料。它的最大收入来自钛技术部门。钛技术部门是 TiO2 颜料的生产商，这是一种优质白色颜料，用于在各种应用中提供白度、亮度、不透明度、耐用性、效率和保护。从地理上看，公司大部分收入来自北美。</p>
</div><h3>Chemours: Delving into Financials</h3>
<div class="lb-trans"><h3>Chemours：深入财务</h3>
</div><p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<div class="lb-trans"><p><strong>市值：</strong> 超过行业标准，公司市值相对于同行处于行业平均水平之上。这强调了其显著的规模和强大的市场地位。</p>
</div><p><strong>Decline in Revenue:</strong> Over the 3M period, Chemours faced challenges, resulting in a decline of approximately <strong>-0.86%</strong> in revenue growth as of 30 September, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<div class="lb-trans"><p><strong>收入下降：</strong> 在过去 3 个月中，Chemours 面临挑战，导致截至 2025 年 9 月 30 日收入增长约下降 <strong>-0.86%</strong>。这意味着公司的顶线收益减少。与同行相比，收入增长落后于行业同行。公司在材料行业的增长率低于同行的平均水平。</p>
</div><p><strong>Net Margin:</strong> Chemours's net margin is impressive, surpassing industry averages. With a net margin of <strong>4.01%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<div class="lb-trans"><p><strong>净利润率：</strong> Chemours 的净利润率令人印象深刻，超过行业平均水平。公司净利润率为 <strong>4.01%</strong>，显示出强大的盈利能力和有效的成本管理。</p>
</div><p><strong>Return on Equity (ROE):</strong> Chemours's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>22.43%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<div class="lb-trans"><p><strong>股本回报率（ROE）：</strong> Chemours 的 ROE 表现突出，超过行业平均水平。公司 ROE 为 <strong>22.43%</strong>，显示出有效利用股本和强大的财务表现。</p>
</div><p><strong>Return on Assets (ROA):</strong> Chemours's ROA excels beyond industry benchmarks, reaching <strong>0.8%</strong>. This signifies efficient management of assets and strong financial health.</p>
<div class="lb-trans"><p><strong>资产回报率（ROA）：</strong> Chemours 的 ROA 超越行业基准，达到 <strong>0.8%</strong>。这表明资产管理高效，财务健康状况良好。</p>
</div><p><strong>Debt Management:</strong> Chemours's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>14.82</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<div class="lb-trans"><p><strong>债务管理：</strong> Chemours 的债务与股本比率显著高于行业平均水平，达到 <strong>14.82</strong>。这表明对借款资金的依赖较重，增加了财务杠杆的担忧。</p>
</div><h2>How Are Analyst Ratings Determined?</h2>
<div class="lb-trans"><h2>分析师评级是如何确定的？</h2>
</div><p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<div class="lb-trans"><p>分析师评级作为股票表现的重要指标，由银行和金融系统的专家提供。这些专家认真分析公司的财务报表，参与电话会议，并与内部人士交流，以生成个别股票的季度评级。</p>
</div><p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<div class="lb-trans"><p>一些分析师发布他们对增长预估、收益和收入等指标的预测，以提供额外的指导。在使用分析师评级时，重要的是要记住，股票和行业分析师也是人，他们只是向投资者提供他们的意见。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并经过编辑审核。</p>
</div>

通过五位分析师的视角，了解对 Chemours 的专家展望